This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Nov 24:371:m4576.

doi: 10.1136/bmj.m4576.

Covid-19: What do we know about the late stage vaccine candidates?

Elisabeth Mahase¹

Affiliations

PMID: 33234507
DOI: 10.1136/bmj.m4576

Covid-19: What do we know about the late stage vaccine candidates?

Elisabeth Mahase. BMJ. 2020.

. 2020 Nov 24:371:m4576.

doi: 10.1136/bmj.m4576.

Author

Elisabeth Mahase¹

Affiliation

¹ The BMJ.

PMID: 33234507
DOI: 10.1136/bmj.m4576

No abstract available

PubMed Disclaimer

Comment in

Unwarranted optimism about vaccine efficacy.
Skegg D, Pearce N. Skegg D, et al. BMJ. 2020 Dec 23;371:m4918. doi: 10.1136/bmj.m4918. BMJ. 2020. PMID: 33361115 No abstract available.

LinkOut - more resources

Full Text Sources
- HighWire

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Covid-19: What do we know about the late stage vaccine candidates?

Affiliation

Covid-19: What do we know about the late stage vaccine candidates?

Author

Affiliation

Comment in

LinkOut - more resources

Full Text Sources